Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations
Open Access
- 24 July 2019
- journal article
- review article
- Published by Springer Nature in Journal of Gastroenterology
- Vol. 54 (10) , 837-844
Abstract
This report explores two hypotheses regarding eosinophilic esophagitis (EoE): (1) that the use of proton pump inhibitors (PPIs) might contribute to the pathogenesis of EoE by preventing peptic digestion of food allergens, by increasing gastric mucosal permeability to enable gastric absorption of those undegraded food allergens, and by causing microbial dysbiosis, and (2) that EoE, like eosinophilic gastroenteritis, might have mucosal-predominant and muscle-predominant forms, and that the muscle-predominant form of EoE might cause a variety of esophageal motility disorders including achalasia.Keywords
This publication has 70 references indexed in Scilit:
- Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002–2009PLOS ONE, 2013
- Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis CellsPLOS ONE, 2012
- γδ T Lymphocytes Coordinate Eosinophil Influx during Allergic ResponsesFrontiers in Pharmacology, 2012
- Esophageal Dysmotility in Children With Eosinophilic EsophagitisAmerican Journal of Gastroenterology, 2009
- Disturbances of Esophageal Motility in Eosinophilic Esophagitis: A Case SeriesDysphagia, 2009
- Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitisGut, 2009
- Esomeprazole induces upper gastrointestinal tract transmucosal permeability increaseAlimentary Pharmacology & Therapeutics, 2008
- Review article: human pepsins – their multiplicity, function and role in reflux diseaseAlimentary Pharmacology & Therapeutics, 2006
- Review article: proton pump inhibitors and bacterial overgrowthAlimentary Pharmacology & Therapeutics, 2005
- Esophageal eosinophilia with dysphagiaDigestive Diseases and Sciences, 1993